Skip to content
Search

Latest Stories

Government allows pharmacists and others to administer naloxone to curb drug-related deaths

Pharmacists across the UK can administer the lifesaving medicine naloxone, the new consultation launched by the government to make the medicine widely available in the community said. 

Under the new plans to tackle record-high drug-related deaths the lifesaving medicine that can reverse the effects of an opioid overdose will be available to more frontline workers. 


A new consultation launched on Tuesday (August 3) amends the current regulations to allow naloxone to be supplied and administered by a wider group of people regularly coming into contact with drug users.

Police officers, prison officers, paramedics and pharmacists are among the professions that would be given access to the drug able to help save the lives of people suffering an overdose.

Health and Social Care Secretary Sajid Javid said: "To prevent people dying from drug abuse we need to make sure the right treatment and medicines are available, which is why we’re launching this consultation on naloxone."

"This government is committed to tackling drug misuse and saving lives, including through our new Joint Combating Drugs Unit and an ambitious new strategy."

The 8-week consultation comes after the government launched a new Joint Combating Drugs Unit and committed to publish an ambitious new drug strategy later this year to tackle drug misuse across society.

Currently, while naloxone can be legally administered by anyone during an emergency, its supply is tightly controlled and is only available through prescription.

Aside from an emergency, it is only commissioned drug treatment services that can obtain, and supply naloxone to individuals without a prescription or other written authorisation. This consultation seeks to change that.

The services and individuals that would be eligible to hold and give naloxone are- police officers, prison officers, probation officers, registered nurses, paramedics, midwives, pharmacists, outreach and day services for people who experience homelessness, and temporary and supported accommodation services for substance users and people who experience homelessness. 

The proposed legislative changes would apply throughout the United Kingdom and this consultation is being made available in England, Wales, Scotland and Northern Ireland.

It seeks views on the viability of these proposals, as well as suggestions from stakeholders of any more individuals or services that should also be included in the list.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less